Citation Impact
Citing Papers
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions
2007
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Head and neck squamous cell carcinoma
2020 Standout
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
2006
New Technology and Health Care Costs — The Case of Robot-Assisted Surgery
2010 Standout
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis
2001
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis
2005
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines
1993 Standout
Prevention of Radiation-Induced Oral Cavity Mucositis by Plasmid/Liposome Delivery of the Human Manganese Superoxide Dismutase (SOD2) Transgene
2003
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer
2001
Quality of life bibliography and indexes: 1993 update
1995
Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome
2008 Standout
The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity
1996
Evolution of quality of life assessment in head and neck cancer
1995
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer
2001
Treatment of head and neck cancer: the role of chemotherapy
1996
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Oral Cancer and Precancerous Lesions
2002 Standout
Toxicity in head and neck cancer: a review of trends and issues
2000
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer
1997
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma
2005
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma
2005
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
Life-satisfaction in patients with head and neck cancer
1995
The chemoradiation paradigm in head and neck cancer
2007
EAU Guidelines on Prostate Cancer
2007 Standout
The pathobiology of mucositis
2004 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: final report
1998
Reactive oxygen species in cancer
2010 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy
1997
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Toxicity antagonists in head and neck cancer
1998
Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer
1998
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma
2008
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancer
2005
Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer Patients
1994
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Longitudinal assessment of quality of life in laryngeal cancer patients
1996
Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long‐term survivors
2002
Head and Neck Cancer
2001 Standout
Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma
1998
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients
2005
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.
2000
Concomitant Chemoradiotherapy as Primary Therapy for Locoregionally Advanced Head and Neck Cancer
2000
A systematic review of patient‐reported outcome measures in head and neck cancer surgery
2007
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
The role of radiotherapy in cancer treatment
2005 Standout
Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer
2008
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory.
2001 Standout
Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
1999 Standout
Quality of Life and Performance in Advanced Head and Neck Cancer Patients on Concomitant Chemoradiotherapy: A Prospective Examination
1999
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
2008 Standout
Hyperfractionated Radiation Therapy With or Without Concurrent Low-Dose Daily Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Prospective Randomized Trial
2000
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy
2004
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
2006
Cancer de la prostate
2007
Works of L. Eapen being referenced
Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer
2004
The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer.
1993
Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.
1994
The role of palliative radiotherapy in advanced head and neck cancer.
1996